Glucagon-like peptide-1 (GLP-1) receptor agonists, originally developed for type-2 diabetes, have become the wealthy and elites darlings of weight management, as they mimic a gut hormone to curb appetite and regulate blood sugar
PlexusDx works with licensed compounding pharmacies to provide personalized GLP-1 therapy that accounts for your digestive health status
Novo Nordisk, the maker of Ozempic and Wegovy, said drugs in this class have been used safely for years to treat diabetes and obesity
A SAFETY NOTE: Common side effects include nausea, vomiting, and diarrhea (here, it is worth mentioning that severe abdominal pain may indicate pancreatitis
Finally, the relatively short duration of follow-up in Blackman et al
Improvements in Mental Health and Lifestyle In addition to reductions in food noise, participants reported several positive psychological and behavioral outcomes: 83% were satisfied or highly satisfied with their current weight-management treatment